Machine learning unlocks blood test secrets for spinal cord injury
Routine blood samples, such as those taken daily at any hospital and tracked over time, could help predict…
WHO’s new report highlights the urgent need to address NCDs and mental health
The World Health Organization (WHO) today released a new report titled “Saving lives, spending less”, revealing that an…
New study reveals a 25-year rise in alcohol-induced mortality
In an analysis by race, sex, age, and geography, alcohol-induced death rates in 2024 are nearly double those in…
Deep learning algorithm uses mammograms and age for heart disease prediction
A new machine learning model developed by The George Institute for Global Health can successfully predict heart disease…
HIIT boosts anti-cancer proteins and slows breast cancer growth
Scientists discovered that just one round of exercise can change blood chemistry in breast cancer survivors, releasing proteins…
Researchers reveal why global gains against chronic diseases are stalling
Despite overall declines in premature non-communicable disease deaths, the study reveals faltering progress driven by uneven regional trends…
Higher PHQ-9 score levels and neutrophil-to-lymphocyte ratio are associated with increased risks of stroke, all-cause mortality, and MACE in NHANES 2005–2018 | BMC Psychiatry
Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a…
Progress stalls in fight against chronic diseases. These European countries have fared best
Published on 11/09/2025 – 6:00 GMT+2 ADVERTISEMENT Deaths from chronic diseases such as cancer, heart disease, and neurological…
Chronic illness death rates decline but pace of progress slows
Death rates from chronic diseases have fallen in four out of five countries around the world in the…
Planetary health diet links to longer life and lower emissions
A large US-UK analysis shows that eating more plant-forward meals and fewer animal-source foods is associated with a…
Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…